Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Abstract/Summary Objective To compare different statistical models for combining N-of-1 trials to estimate a population treatment effect. Study Design and Setting Data from a published series of N-of-1 trials comparing amitriptyline therapy and combination treatment (amitriptyline + fluoxetine ) were analyzed to compare summary and individual participant data meta-analysis, repeated measures models, Bayesian hierarchical models, single-period, single-pair and averaged outcome crossover models. Results The best fitting model included a random intercept (response on amitriptyline) and fixed treatment effect (added fluoxetine). Results supported a common, uncorrelated within-patient covariance structure that is equal between-treatments and across patients. Assuming unequal within-patient variances, a random effects model was favored. Bayesian hierarchical models improved precision and were highly sensitive to within-patient variance priors. Conclusion Optimal models for combining N-of-1 trials need to consider goals, data sources, and relative within and between patient variances. Without sufficient patients, between-patient variation will be hard to explain with covariates. N-of-1 data with few observations per patients may not support models with heterogeneous within-patient variation. With common variances, models appear robust. Bayesian models may improve parameter estimation but are sensitive to prior assumptions about variance components. With limited resources, improving within-patient precision must be balanced by increased participants to explain population variation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Data Analysis Using Regression and Multilevel/Hierarchical Models
Gelman, A., & Hill, J. (2006) · doi:10.1017/cbo9780511790942 · Cited by 13,597
Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence
Singer, J. D., & Willett, J. B. (2003) · doi:10.1093/acprof:oso/9780195152968.001.0001 · Cited by 10,647
The combination of estimates from different experiments
Cochran, W. G. (1954) · Biometrics · doi:10.2307/3001666 · Cited by 5,380
Gelman, A. (2006) · Bayesian Analysis · doi:10.1214/06-ba117a · Cited by 4,050
Meta‐Analysis Of Controlled Clinical Trials
Whitehead, A. (2002) · doi:10.1002/0470854200 · Cited by 827
Research works printed but not linked: 20
- Guyatt, 1986, Determining optimal therapy randomized trials in individual patients, N Engl J Med, 314, 889, 10.1056/NEJM198604033141406 · DOI · Paper page
- Zucker, 1997, Combining single patient (N-of-1) trials to estimate population treatment effects and to evaluate individual patient responses to treatment, J Clin Epidemiol, 50, 401, 10.1016/S0895-4356(96)00429-5 · DOI · Paper page
- March, 1994, n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis, BMJ, 309, 1041, 10.1136/bmj.309.6961.1041 · DOI
- Jaeschke, 1991, Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials, J Rheumatol, 18, 447
- Zucker, 2006, Lessons learned combining N-of-1 trials to assess fibromyalgia therapies 1, J Rheumatol, 33, 2069
- Mahon, 1999, Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice, Chest, 115, 38, 10.1378/chest.115.1.38 · DOI
- Johannessen, 1992, Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials, Scand J Gastroenterol, 27, 189, 10.3109/00365529208999947 · DOI
- Guyatt, 1990, The n-of-1 randomized controlled trial: clinical usefulness. Our three-year experience, Ann Intern Med, 112, 293, 10.7326/0003-4819-112-4-293 · DOI · Paper page
- Larson, 1993, Randomized clinical trials in single patients during a 2-year period, JAMA, 270, 2708, 10.1001/jama.1993.03510220064035 · DOI · Paper page
- Guyatt, 1990, N of 1 randomized trials for investigating new drugs, Control Clin Trials, 11, 88, 10.1016/0197-2456(90)90003-K · DOI
- Guyatt, 1988, A clinician's guide for conducting randomized trials in individual patients, CMAJ, 139, 497
- Avins, 2005, Use of an embedded N-of-1 trial to improve adherence and increase information from a clinical study, Contemp Clin Trials, 26, 397, 10.1016/j.cct.2005.02.004 · doi:10.1016/j.cct.2005.02.004
- DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
- Whitehead, 2001, Meta-analysis of ordinal outcomes using individual patient data, Stat Med, 20, 2243, 10.1002/sim.919 · DOI · Paper page
- Higgins, 2001, Meta-analysis of continuous outcome data from individual patients, Stat Med, 20, 2219, 10.1002/sim.918 · DOI · Paper page
- Ishak, 2007, Meta-analysis of longitudinal studies 1, Clin Trials, 4, 525, 10.1177/1740774507083567 · DOI · Paper page
- Burckhardt, 1991, The fibromyalgia impact questionnaire: development and validation, J Rheumatol, 18, 728
- Schwarz, 1978, Estimating the dimension of a model, Ann Stat, 6, 461, 10.1214/aos/1176344136 · DOI · Paper page
- Goldenberg, 1996, A randomized, double-blind crossover trial of fluoxetine and amitriptyline in the treatment of fibromyalgia, Arthritis Rheum, 39, 1852, 10.1002/art.1780391111 · DOI · Paper page
- Lau, 1995, Cumulative meta-analysis of clinical trials builds evidence for exemplary medical care, J Clin Epidemiol, 48, 45, 10.1016/0895-4356(94)00106-Z · DOI · Paper page
Cited by
From ideas to efficacy: The ORBIT model for developing behavioral treatments for chronic diseases
Czajkowski, S. M., Powell, L. H., Adler, N., Naar-King, S., Reynolds, K. D., Hunter, C. M., Laraia, B., Olster, D. H., Perna, F. M., Peterson, J. C., et al. (2015) · Health Psychology · doi:10.1037/hea0000161 · Cited by 1,161
The n-of-1 clinical trial: the ultimate strategy for individualizing medicine?
Lillie, E. O., Patay, B., Diamant, J., Issell, B., Topol, E. J., & Schork, N. J. (2011) · Personalized Medicine · doi:10.2217/pme.11.7 · Cited by 706
Rapid, responsive, relevant (R3) research: a call for a rapid learning health research enterprise
Riley, W. T., Glasgow, R. E., Etheredge, L., & Abernethy, A. P. (2013) · Clinical and Translational Medicine · doi:10.1186/2001-1326-2-10 · Cited by 267
“medicine approach [16], and Bayesian analyses from a series of such trials [17] may provide sufficient evidence”
BackgroundDuan, N., Kravitz, R. L., & Schmid, C. H. (2013) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.04.006 · Cited by 239
Self-citationN-of-1 Trials in the Medical Literature: A Systematic Review
Gabler, N. B., Duan, N., Vohra, S., & Kravitz, R. L. (2011) · Medical Care · doi:10.1097/mlr.0b013e318215d90d · Cited by 226
Metadata
- Authors
- Zucker, D. R., Ruthazer, R., & Schmid, C. H.
- Venue
- Journal of Clinical Epidemiology
- Publisher
- Elsevier BV
- Published
- 2010-12
- Volume
- 63
- Issue
- 12
- Pages
- 1312-1323
- ISSN
- 0895-4356 (ISSN-L)
- OpenAlex
- W2133197025
- Cited by
- 184
- References
- 5
- FWCI
- 3.50
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (RO1 AR45416)
- The National Institute of Arthritis and Musculoskeletal and Skin Diseases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. https://app.cochat.ai/papers/10.1016/j.jclinepi.2010.04.020
- The paper
- Zucker, D. R., Ruthazer, R., & Schmid, C. H. (2010). Individual (N-of-1) trials can be combined to give population comparative treatment effect estimates: methodologic considerations. Journal of Clinical Epidemiology. https://doi.org/10.1016/j.jclinepi.2010.04.020
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.